Apolipoprotein E is an HIV-1-inducible inhibitor of viral production and infectivity in macrophages. 2018

Rokeya Siddiqui, and Shinya Suzu, and Mikinori Ueno, and Hesham Nasser, and Ryota Koba, and Farzana Bhuyan, and Osamu Noyori, and Sofiane Hamidi, and Guojun Sheng, and Mariko Yasuda-Inoue, and Takayuki Hishiki, and Sayaka Sukegawa, and Eri Miyagi, and Klaus Strebel, and Shuzo Matsushita, and Kunitada Shimotohno, and Yasuo Ariumi
Center for AIDS Research, Kumamoto University, Kumamoto, Japan.

Apolipoprotein E (ApoE) belongs to a class of cellular proteins involved in lipid metabolism. ApoE is a polymorphic protein produced primarily in macrophages and astrocytes. Different isoforms of ApoE have been associated with susceptibility to various diseases including Alzheimer's and cardiovascular diseases. ApoE expression has also been found to affect susceptibility to several viral diseases, including Hepatitis C and E, but its effect on the life cycle of HIV-1 remains obscure. In this study, we initially found that HIV-1 infection selectively up-regulated ApoE in human monocyte-derived macrophages (MDMs). Interestingly, ApoE knockdown in MDMs enhanced the production and infectivity of HIV-1, and was associated with increased localization of viral envelope (Env) proteins to the cell surface. Consistent with this, ApoE over-expression in 293T cells suppressed Env expression and viral infectivity, which was also observed with HIV-2 Env, but not with VSV-G Env. Mechanistic studies revealed that the C-terminal region of ApoE was required for its inhibitory effect on HIV-1 Env expression. Moreover, we found that ApoE and Env co-localized in the cells, and ApoE associated with gp160, the precursor form of Env, and that the suppression of Env expression by ApoE was cancelled by the treatment with lysosomal inhibitors. Overall, our study revealed that ApoE is an HIV-1-inducible inhibitor of viral production and infectivity in macrophages that exerts its anti-HIV-1 activity through association with gp160 Env via the C-terminal region, which results in subsequent degradation of gp160 Env in the lysosomes.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001053 Apolipoproteins Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES. Apolipoprotein
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

Rokeya Siddiqui, and Shinya Suzu, and Mikinori Ueno, and Hesham Nasser, and Ryota Koba, and Farzana Bhuyan, and Osamu Noyori, and Sofiane Hamidi, and Guojun Sheng, and Mariko Yasuda-Inoue, and Takayuki Hishiki, and Sayaka Sukegawa, and Eri Miyagi, and Klaus Strebel, and Shuzo Matsushita, and Kunitada Shimotohno, and Yasuo Ariumi
April 2016, Cell host & microbe,
Rokeya Siddiqui, and Shinya Suzu, and Mikinori Ueno, and Hesham Nasser, and Ryota Koba, and Farzana Bhuyan, and Osamu Noyori, and Sofiane Hamidi, and Guojun Sheng, and Mariko Yasuda-Inoue, and Takayuki Hishiki, and Sayaka Sukegawa, and Eri Miyagi, and Klaus Strebel, and Shuzo Matsushita, and Kunitada Shimotohno, and Yasuo Ariumi
February 2008, Virology,
Rokeya Siddiqui, and Shinya Suzu, and Mikinori Ueno, and Hesham Nasser, and Ryota Koba, and Farzana Bhuyan, and Osamu Noyori, and Sofiane Hamidi, and Guojun Sheng, and Mariko Yasuda-Inoue, and Takayuki Hishiki, and Sayaka Sukegawa, and Eri Miyagi, and Klaus Strebel, and Shuzo Matsushita, and Kunitada Shimotohno, and Yasuo Ariumi
August 2018, The Journal of biological chemistry,
Rokeya Siddiqui, and Shinya Suzu, and Mikinori Ueno, and Hesham Nasser, and Ryota Koba, and Farzana Bhuyan, and Osamu Noyori, and Sofiane Hamidi, and Guojun Sheng, and Mariko Yasuda-Inoue, and Takayuki Hishiki, and Sayaka Sukegawa, and Eri Miyagi, and Klaus Strebel, and Shuzo Matsushita, and Kunitada Shimotohno, and Yasuo Ariumi
January 2022, Proceedings of the National Academy of Sciences of the United States of America,
Rokeya Siddiqui, and Shinya Suzu, and Mikinori Ueno, and Hesham Nasser, and Ryota Koba, and Farzana Bhuyan, and Osamu Noyori, and Sofiane Hamidi, and Guojun Sheng, and Mariko Yasuda-Inoue, and Takayuki Hishiki, and Sayaka Sukegawa, and Eri Miyagi, and Klaus Strebel, and Shuzo Matsushita, and Kunitada Shimotohno, and Yasuo Ariumi
September 2000, International journal of molecular medicine,
Rokeya Siddiqui, and Shinya Suzu, and Mikinori Ueno, and Hesham Nasser, and Ryota Koba, and Farzana Bhuyan, and Osamu Noyori, and Sofiane Hamidi, and Guojun Sheng, and Mariko Yasuda-Inoue, and Takayuki Hishiki, and Sayaka Sukegawa, and Eri Miyagi, and Klaus Strebel, and Shuzo Matsushita, and Kunitada Shimotohno, and Yasuo Ariumi
July 1990, AIDS research and human retroviruses,
Rokeya Siddiqui, and Shinya Suzu, and Mikinori Ueno, and Hesham Nasser, and Ryota Koba, and Farzana Bhuyan, and Osamu Noyori, and Sofiane Hamidi, and Guojun Sheng, and Mariko Yasuda-Inoue, and Takayuki Hishiki, and Sayaka Sukegawa, and Eri Miyagi, and Klaus Strebel, and Shuzo Matsushita, and Kunitada Shimotohno, and Yasuo Ariumi
December 2007, Journal of virology,
Rokeya Siddiqui, and Shinya Suzu, and Mikinori Ueno, and Hesham Nasser, and Ryota Koba, and Farzana Bhuyan, and Osamu Noyori, and Sofiane Hamidi, and Guojun Sheng, and Mariko Yasuda-Inoue, and Takayuki Hishiki, and Sayaka Sukegawa, and Eri Miyagi, and Klaus Strebel, and Shuzo Matsushita, and Kunitada Shimotohno, and Yasuo Ariumi
September 2005, Virology,
Rokeya Siddiqui, and Shinya Suzu, and Mikinori Ueno, and Hesham Nasser, and Ryota Koba, and Farzana Bhuyan, and Osamu Noyori, and Sofiane Hamidi, and Guojun Sheng, and Mariko Yasuda-Inoue, and Takayuki Hishiki, and Sayaka Sukegawa, and Eri Miyagi, and Klaus Strebel, and Shuzo Matsushita, and Kunitada Shimotohno, and Yasuo Ariumi
February 2022, Journal of virology,
Rokeya Siddiqui, and Shinya Suzu, and Mikinori Ueno, and Hesham Nasser, and Ryota Koba, and Farzana Bhuyan, and Osamu Noyori, and Sofiane Hamidi, and Guojun Sheng, and Mariko Yasuda-Inoue, and Takayuki Hishiki, and Sayaka Sukegawa, and Eri Miyagi, and Klaus Strebel, and Shuzo Matsushita, and Kunitada Shimotohno, and Yasuo Ariumi
June 1996, AIDS (London, England),
Copied contents to your clipboard!